newsfilter
← Latest News
Business Wire·

Glaukos Receives Permanent J-code for Epioxa™

New J-code for Epioxa™, J2789, set to become effective July 1, 2026 Glaukos Corporation (NYSE:GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of